First Wave BioPharma: Funding, Investors & Team (Sep 2026)
First Wave BioPharma is a biopharmaceutical company at the clinical stage that focuses on creating targeted treatments for gastrointestinal (GI) disorders which do not affect the entire body.
First Wave BioPharma has raised $20.2M across 6 funding rounds on record, the most recent an undisclosed round of $4.0M announced in Mar 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
First Wave BioPharma Company Profile and Key Stats
Latest funding round on record: Mar 2024.
First Wave BioPharma Funding Rounds
First Wave BioPharma raised $3.0M in a Post-IPO Equity announced in Jul 2021.
1 years later, a Post-IPO Equity of $300k was announced in Jul 2022.
3 months later, a Post-IPO Equity of $6.0M was announced in Oct 2022.
9 months later, an undisclosed round of $2.1M was announced in Jul 2023.
5 months later, an undisclosed round of $4.8M was announced in Dec 2023.
3 months later, an undisclosed round of $4.0M was announced in Mar 2024.
First Wave BioPharma Founders and Leadership Team
Contact details for the First Wave BioPharma team: 2 of 3 have an email address on file.
Start 14-day free trial →First Wave BioPharma Funding Compared to Other Biotechnology Startups
First Wave BioPharma's latest round of $4.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like First Wave BioPharma in Biotechnology and Brooklyn
Companies Similar to First Wave BioPharma
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
First Wave BioPharma Funding FAQs
What does First Wave BioPharma do?
First Wave BioPharma is a biopharmaceutical company at the clinical stage that focuses on creating targeted treatments for gastrointestinal (GI) disorders which do not affect the entire body.
How much funding has First Wave BioPharma raised?
First Wave BioPharma has raised $20.2M across 6 rounds on record. The most recent is an undisclosed round of $4.0M announced in Mar 2024.
When did First Wave BioPharma last raise funding?
First Wave BioPharma's most recent funding round on record is an undisclosed round of $4.0M, announced in Mar 2024.
Who founded First Wave BioPharma?
FundedIQ lists Daniel Dupret (Founder) at First Wave BioPharma.
Who is the CEO of First Wave BioPharma?
James Sapirstein is listed as CEO at First Wave BioPharma.
Where is First Wave BioPharma headquartered?
First Wave BioPharma is based in Brooklyn, New York, United States.
How many employees does First Wave BioPharma have?
First Wave BioPharma is in the 11-50 employee band.
How does First Wave BioPharma's funding compare to other Biotechnology startups?
First Wave BioPharma's latest round of $4.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's First Wave BioPharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for First Wave BioPharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.